AstraZeneca PLC (AZN)
After hours:
| Previous close | 66.08 |
| Open | 67.34 |
| Bid | 0.00 x 1200 |
| Ask | 0.00 x 1400 |
| Day's range | 66.40 - 67.99 |
| 52-week range | 52.65 - 71.70 |
| Volume | |
| Avg. volume | 6,314,183 |
| Market cap | 212.276B |
| Beta (5Y monthly) | 0.17 |
| PE ratio (TTM) | 106.20 |
| EPS (TTM) | 0.64 |
| Earnings date | N/A |
| Forward dividend & yield | 1.45 (2.19%) |
| Ex-dividend date | 11 Aug 2022 |
| 1y target est | 71.90 |
- Motley Fool
Why Shares of Compugen Rose 16.5% on Wednesday
Shares of Compugen (NASDAQ: CGEN), a clinical-stage biotech company that specializes in immunology therapies to treat cancer, saw its shares rise 16.5% on Wednesday. The stock closed on Tuesday at $1.03, then opened on Wednesday at $1.01, before jumping to $1.23 in the late afternoon and closing at $1.20. The stock has been volatile, with a 52-week low of $0.51 and a 52-week high of $4.88.
- Zacks
AstraZeneca (AZN) Boosts Cell Therapies With Neogene Deal
The acquisition of Neogene is set to give AstraZeneca (AZN) access to the latter's next-generation T-cell receptor therapies.
- Business Wire
AstraZeneca Showcases Strength of Hematology Portfolio and Pipeline Across Multiple Hard-to-Treat Conditions at ASH 2022
WILMINGTON, Del., November 30, 2022--AstraZeneca will present 47 abstracts showcasing new data from across its hematology portfolio and clinical pipeline, demonstrating its commitment to redefining care for hard-to-treat blood diseases at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition, December 10 to 13, 2022.
